Are long-term remissions possible with hormonal therapy only? Post hoc analysis of EMBARK examining sustained prostate-specific antigen (PSA) <0.2 ng/mL despite testosterone (T) recovery after treatment (tx) suspension.
| Publicado en: | Journal of Clinical Oncology Vol. 44; pp. 189 - 474 |
|---|---|
| Autores principales: | , , , , , , , , , , , |
| Formato: | Journal Article |
| Publicado: |
American Society of Clinical Oncology
2026 Supplement 7
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=192013839&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 192013839 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 0732183X 20D jtl: Journal of Clinical Oncology issn: 0732183X maglogo: N pubinfo: dt: 2026 Supplement 7 vid: 44 pid: 26892 pub: American Society of Clinical Oncology place: Alexandria, Virginia artinfo: ui: 192013839 10.1200/JCO.2026.44.7_suppl.189 192013839 ppf: 189 ppct: 285 formats: tig: atl: Are long-term remissions possible with hormonal therapy only? Post hoc analysis of EMBARK examining sustained prostate-specific antigen (PSA) <0.2 ng/mL despite testosterone (T) recovery after treatment (tx) suspension. aug: au: Shore, Neal D. De Giorgi, Ugo Gleave, Martin Kalac, Matko Tang, Yiyun Croitoru, Ruslan Rosales, Matt Patel, Manish Finelli, Antonio Schiffman, Zvi Lantz, Anna Freedland, Stephen J. affil: START Carolinas/Carolina Urologic Research Center, Myrtle Beach, SC sug: pubtype: Academic Journal doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|